Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Atrial fibrillation.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Heart and blood vessels | 1 | Atrial fibrillation |
No clinical trials have been registered for atrial fibrillation, familial, 5.
3 publications have been identified in PubMed for atrial fibrillation, familial, 5. Research spans Case Report / Case Series (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
Martínez-Barrios E (2026). [PMID: 41596527](https://pubmed.ncbi.nlm.nih.gov/41596527/). *International journal of molecular sciences*. [Basic Science / Preclinical]
Ricci F (2025). [PMID: 41206697](https://pubmed.ncbi.nlm.nih.gov/41206697/). *Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology*. [Epidemiology / Natural History]
Nomura Y (2025). [PMID: 40697198](https://pubmed.ncbi.nlm.nih.gov/40697198/). *Journal of cardiology cases*. [Case Report / Case Series]
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:57 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
AI-curated news mentioning atrial fibrillation, familial, 5
Updated Sep 9, 2026
An updated meta-analysis investigates the relationship between tirzepatide and the incidence of atrial fibrillation in adults with overweight or obesity. The findings contribute to understanding the cardiovascular safety profile of tirzepatide in this patient population.
A recent case series highlights life-threatening delayed myocardial ischemia and ventricular arrhythmias following pulmonary vein isolation (PFA) for atrial fibrillation (AF). This study underscores the potential risks associated with PFA procedures, emphasizing the need for careful patient monitoring.
New research demonstrates that multi-trait polygenic risk scores enhance the genomic prediction of atrial fibrillation across various ancestries. This advancement could lead to improved risk assessment and personalized treatment strategies for patients.